FDA Authorizes New COVID Vaccines for 2024-25

Updated COVID-19 vaccines from Pfizer and Moderna, designed to target the latest strains of the virus, have received emergency use authorization from the U.S. FDA and will soon be available. These vaccines are expected to be more effective against current variants, and health officials are urging the public to get vaccinated, especially those at higher risk. In regions like Lexington and Virginia, the rollout is anticipated to begin as early as next week, while Health Canada aims to complete its review by early autumn. Amid a summer surge in COVID-19 cases, local health departments and pharmacies are preparing to offer these vaccines, emphasizing their importance in reducing severe illness and hospitalizations. The vaccines are approved for individuals six months and older, with the CDC recommending vaccinations in September or October to boost protection against potential winter waves.